Stock Screener
| # | Symbol | Price | Change % | Market Cap▼ | Volume | Name | 1 Week % | 1 Month % | 3 Month % | 6 Month % | 1 Year % | Equity Type | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVO | 41.65 | +2.45 | 183.6B | 11.7M | Novo-Nordisk A/S | +0.64 | +7.25 | -7.21 | -6.92 | -14.06 | ADR | Biotechnology |
| 2 | NONOF | 41.24 | +0.62 | 139.8B | 35.5K | NOVO NORDISK A/S B NEW | +0.09 | +6.19 | -8.57 | -7.76 | -12.71 | Common Stock | Biotechnology |
| 3 | VRTX | 538.67 | -0.73 | 136.6B | 756.2K | Vertex Pharmaceuticals Inc | -2.21 | +7.79 | +4.49 | +23.28 | +24.11 | Common Stock | Biotechnology |
| 4 | REGN | 955.36 | +0.44 | 98.8B | 1.2M | Regeneron Pharmaceuticals Inc | +3.85 | +20.82 | +18.54 | +36.82 | +35.65 | Common Stock | Biotechnology |
| 5 | MRNA | 223.22 | -3.51 | 90.3B | 8.1M | Moderna, Inc. Common Stock | -17.02 | +2.39 | +246.29 | +355.18 | +801.53 | Common Stock | Biotechnology |
| 6 | CMXHF | 136.78 | -1.71 | 66.1B | 350 | CSL LTD | 0.00 | +10.49 | +22.91 | +94.01 | +18.21 | Common Stock | Biotechnology |
| 7 | UCBJY | 163.75 | +0.83 | 63.7B | 14.1K | UCB SA UNSP/ADR | -2.39 | +43.06 | +31.62 | +19.48 | +24.40 | ADR | Biotechnology |
| 8 | UCBJF | 318.75 | -4.39 | 62.0B | 956 | UCB SA NPV | -2.88 | +33.29 | +25.20 | +10.25 | +18.34 | Common Stock | Biotechnology |
| 9 | ARGX | 959.27 | -2.25 | 60.3B | 225.9K | argenx SE | -0.31 | +17.11 | -2.89 | +20.01 | +3.19 | ADR | Biotechnology |
| 10 | RVMD | 172.05 | -2.44 | 37.2B | 2.7M | Revolution Medicines, Inc. Common Stock | -14.04 | -3.32 | -18.84 | +18.12 | +148.84 | Common Stock | Biotechnology |
| 11 | GNMSF | 509.50 | -5.82 | 33.7B | 985 | GENMAB A/S DKK | -6.68 | +34.79 | +59.22 | +92.07 | +67.05 | Common Stock | Biotechnology |
| 12 | CSLLY | 34.41 | -0.75 | 33.3B | 35.6K | CSL LTD SP/ADR | -2.10 | +3.18 | +43.67 | +97.64 | -40.63 | ADR | Biotechnology |
| 13 | GMAB | 51.37 | -0.72 | 31.7B | 3.7M | Genmab A/S ADS | -7.95 | +38.82 | +56.41 | +93.54 | +68.85 | ADR | Biotechnology |
| 14 | RPRX | 69.30 | +0.48 | 30.9B | 3.0M | Royalty Pharma plc Class A | +0.77 | +13.68 | +16.57 | +31.13 | +76.97 | Common Stock | Biotechnology |
| 15 | ROIV | 39.53 | -1.14 | 28.6B | 7.2M | Roivant Sciences Ltd. Common Shares | -2.79 | +17.91 | +9.09 | +34.98 | +92.29 | Common Stock | Biotechnology |
| 16 | INSM | 121.10 | +2.57 | 26.6B | 1.5M | Insmed, Inc. | +4.31 | +25.79 | -5.63 | +10.96 | -38.65 | Common Stock | Biotechnology |
| 17 | WXIBF | 6.15 | -0.97 | 25.5B | 1.7K | WUXI BIOLOGICS CAY NEW | -0.48 | -3.30 | -0.81 | +46.08 | +47.84 | Common Stock | Biotechnology |
| 18 | UTHR | 591.12 | -0.37 | 25.2B | 463.5K | United Therapeutics Corp | +1.49 | +10.88 | +16.25 | +3.96 | +25.26 | Common Stock | Biotechnology |
| 19 | WXXWY | 11.97 | -2.84 | 24.9B | 77.0K | WUXI BIOLOGICS UNSP/ADR | -4.32 | -4.70 | +1.70 | +40.82 | +45.98 | ADR | Biotechnology |
| 20 | INCY | 120.95 | -0.61 | 24.7B | 950.5K | Incyte Genomics Inc | -0.77 | +6.97 | -2.06 | +26.91 | +16.11 | Common Stock | Biotechnology |